NSG 6998 APEA PREDICTOR EXAM ENDOCRINOLOGY FOCUSED ACTUAL
EXAM 2026/2027 | ENDOCRINE & METABOLIC DISORDERS | 100 QUESTIONS |
100% VERIFIED ANSWERS | PASS GUARANTEED | ALREADY GRADED A+
COURSE: NSG 6998: APEA Predictor Exam
INSTITUTION: Advanced Practice Education Associates
ACADEMIC YEAR: 2026/2027 | Latest Update
EXAM TYPE: Endocrinology Focused Examination
TOTAL QUESTIONS: 100 | Format: Multiple Choice, Select All That Apply, Clinical Scenarios
GRADE: A+ | 100% Verified Correct Answers with Detailed Rationales
TABLE OF CONTENTS
Section Topic Area Questions
Section 1 Diabetes Mellitus: Type 1 & Type 2 Q1-25
Section 2 Diabetes Complications & Management Q26-35
Section 3 Thyroid Disorders Q36-50
Section 4 Adrenal Disorders Q51-60
Section 5 Pituitary Disorders Q61-70
Section 6 Parathyroid & Calcium Disorders Q71-80
Section 7 Lipid Disorders & Metabolic Syndrome Q81-90
Section 8 Obesity & Weight Management Q91-95
Section 9 Integrated Clinical Scenarios Q96-100
SECTION 1: DIABETES MELLITUS: TYPE 1 & TYPE 2
Q1: A 25-year-old male presents with polyuria, polydipsia, and weight loss over 2 weeks. Random glucose is
350 mg/dL. What is the most likely diagnosis?
A. Type 1 diabetes mellitus. [100% CORRECT]
B. Type 2 diabetes mellitus
C. Diabetes insipidus
D. Hyperthyroidism
, NSG 6998 APEA PREDICTOR EXAM ENDOCRINOLOGY FOCUSED ACTUAL
EXAM 2026/2027 | ENDOCRINE & METABOLIC DISORDERS | 100 QUESTIONS |
100% VERIFIED ANSWERS | PASS GUARANTEED | ALREADY GRADED A+
Correct Answer: A
Rationale: Correct: Type 1 diabetes presents with acute onset, weight loss, and hyperglycemia . Incorrect B:
Gradual onset, often overweight. Incorrect C: Normal glucose. Incorrect D: Not hyperglycemia.
Q2: A 55-year-old obese female presents with fatigue and blurred vision. Fasting glucose is 145 mg/dL. HbA1c
is 7.2%. What is the most likely diagnosis?
A. Type 1 diabetes
B. Type 2 diabetes. [100% CORRECT]
C. Prediabetes
D. Normal
Correct Answer: B
Rationale: Correct: Type 2 diabetes presents with gradual onset in overweight adults . Incorrect A: Acute
onset, weight loss. Incorrect C: HbA1c 5.7-6.4%. Incorrect D: Not normal.
Q3: A patient with type 2 diabetes is started on metformin. What is the mechanism of action?
A. Increases insulin secretion
B. Decreases hepatic glucose production. [100% CORRECT]
C. Slows carbohydrate absorption
D. Increases glucose excretion
Correct Answer: B
, NSG 6998 APEA PREDICTOR EXAM ENDOCRINOLOGY FOCUSED ACTUAL
EXAM 2026/2027 | ENDOCRINE & METABOLIC DISORDERS | 100 QUESTIONS |
100% VERIFIED ANSWERS | PASS GUARANTEED | ALREADY GRADED A+
Rationale: Correct: Metformin decreases hepatic gluconeogenesis . Incorrect A: Sulfonylureas. Incorrect C:
Alpha-glucosidase inhibitors. Incorrect D: SGLT-2 inhibitors.
Q4: A patient with type 2 diabetes is prescribed metformin. Which adverse effect is most common?
A. Hypoglycemia
B. GI upset (nausea, diarrhea). [100% CORRECT]
C. Weight gain
D. Lactic acidosis
Correct Answer: B
Rationale: Correct: GI upset is the most common side effect of metformin . Incorrect A: Low risk. Incorrect C:
Weight neutral. Incorrect D: Rare but serious.
Q5: A patient on metformin reports persistent GI upset. What is the most appropriate next step?
A. Discontinue metformin
B. Switch to extended-release formulation. [100% CORRECT]
C. Double the dose
D. Add another agent
Correct Answer: B
Rationale: Correct: Extended-release metformin often improves GI tolerance . Incorrect A, C, D: Not
appropriate.
, NSG 6998 APEA PREDICTOR EXAM ENDOCRINOLOGY FOCUSED ACTUAL
EXAM 2026/2027 | ENDOCRINE & METABOLIC DISORDERS | 100 QUESTIONS |
100% VERIFIED ANSWERS | PASS GUARANTEED | ALREADY GRADED A+
Q6: A patient with type 2 diabetes and CKD (eGFR 35) is started on metformin. What is the appropriate
action?
A. Use standard dose
B. Use with caution and monitor renal function. [100% CORRECT]
C. Contraindicated
D. Double the dose
Correct Answer: B
Rationale: Correct: Metformin can be used with caution at eGFR 30-45 . Incorrect A: Dose adjustment
needed. Incorrect C: Contraindicated at eGFR <30. Incorrect D: Not appropriate.
Q7: A patient with type 2 diabetes and heart failure is started on empagliflozin. What is the cardiovascular
benefit?
A. Weight loss
B. Reduced mortality and hospitalizations. [100% CORRECT]
C. Blood pressure reduction
D. Improved lipids
Correct Answer: B
Rationale: Correct: SGLT-2 inhibitors reduce CV mortality and HF hospitalizations . Incorrect A, C, D: Also
benefits but not primary.
Q8: A patient with type 2 diabetes is started on empagliflozin. Which adverse effect is specific to this class?
EXAM 2026/2027 | ENDOCRINE & METABOLIC DISORDERS | 100 QUESTIONS |
100% VERIFIED ANSWERS | PASS GUARANTEED | ALREADY GRADED A+
COURSE: NSG 6998: APEA Predictor Exam
INSTITUTION: Advanced Practice Education Associates
ACADEMIC YEAR: 2026/2027 | Latest Update
EXAM TYPE: Endocrinology Focused Examination
TOTAL QUESTIONS: 100 | Format: Multiple Choice, Select All That Apply, Clinical Scenarios
GRADE: A+ | 100% Verified Correct Answers with Detailed Rationales
TABLE OF CONTENTS
Section Topic Area Questions
Section 1 Diabetes Mellitus: Type 1 & Type 2 Q1-25
Section 2 Diabetes Complications & Management Q26-35
Section 3 Thyroid Disorders Q36-50
Section 4 Adrenal Disorders Q51-60
Section 5 Pituitary Disorders Q61-70
Section 6 Parathyroid & Calcium Disorders Q71-80
Section 7 Lipid Disorders & Metabolic Syndrome Q81-90
Section 8 Obesity & Weight Management Q91-95
Section 9 Integrated Clinical Scenarios Q96-100
SECTION 1: DIABETES MELLITUS: TYPE 1 & TYPE 2
Q1: A 25-year-old male presents with polyuria, polydipsia, and weight loss over 2 weeks. Random glucose is
350 mg/dL. What is the most likely diagnosis?
A. Type 1 diabetes mellitus. [100% CORRECT]
B. Type 2 diabetes mellitus
C. Diabetes insipidus
D. Hyperthyroidism
, NSG 6998 APEA PREDICTOR EXAM ENDOCRINOLOGY FOCUSED ACTUAL
EXAM 2026/2027 | ENDOCRINE & METABOLIC DISORDERS | 100 QUESTIONS |
100% VERIFIED ANSWERS | PASS GUARANTEED | ALREADY GRADED A+
Correct Answer: A
Rationale: Correct: Type 1 diabetes presents with acute onset, weight loss, and hyperglycemia . Incorrect B:
Gradual onset, often overweight. Incorrect C: Normal glucose. Incorrect D: Not hyperglycemia.
Q2: A 55-year-old obese female presents with fatigue and blurred vision. Fasting glucose is 145 mg/dL. HbA1c
is 7.2%. What is the most likely diagnosis?
A. Type 1 diabetes
B. Type 2 diabetes. [100% CORRECT]
C. Prediabetes
D. Normal
Correct Answer: B
Rationale: Correct: Type 2 diabetes presents with gradual onset in overweight adults . Incorrect A: Acute
onset, weight loss. Incorrect C: HbA1c 5.7-6.4%. Incorrect D: Not normal.
Q3: A patient with type 2 diabetes is started on metformin. What is the mechanism of action?
A. Increases insulin secretion
B. Decreases hepatic glucose production. [100% CORRECT]
C. Slows carbohydrate absorption
D. Increases glucose excretion
Correct Answer: B
, NSG 6998 APEA PREDICTOR EXAM ENDOCRINOLOGY FOCUSED ACTUAL
EXAM 2026/2027 | ENDOCRINE & METABOLIC DISORDERS | 100 QUESTIONS |
100% VERIFIED ANSWERS | PASS GUARANTEED | ALREADY GRADED A+
Rationale: Correct: Metformin decreases hepatic gluconeogenesis . Incorrect A: Sulfonylureas. Incorrect C:
Alpha-glucosidase inhibitors. Incorrect D: SGLT-2 inhibitors.
Q4: A patient with type 2 diabetes is prescribed metformin. Which adverse effect is most common?
A. Hypoglycemia
B. GI upset (nausea, diarrhea). [100% CORRECT]
C. Weight gain
D. Lactic acidosis
Correct Answer: B
Rationale: Correct: GI upset is the most common side effect of metformin . Incorrect A: Low risk. Incorrect C:
Weight neutral. Incorrect D: Rare but serious.
Q5: A patient on metformin reports persistent GI upset. What is the most appropriate next step?
A. Discontinue metformin
B. Switch to extended-release formulation. [100% CORRECT]
C. Double the dose
D. Add another agent
Correct Answer: B
Rationale: Correct: Extended-release metformin often improves GI tolerance . Incorrect A, C, D: Not
appropriate.
, NSG 6998 APEA PREDICTOR EXAM ENDOCRINOLOGY FOCUSED ACTUAL
EXAM 2026/2027 | ENDOCRINE & METABOLIC DISORDERS | 100 QUESTIONS |
100% VERIFIED ANSWERS | PASS GUARANTEED | ALREADY GRADED A+
Q6: A patient with type 2 diabetes and CKD (eGFR 35) is started on metformin. What is the appropriate
action?
A. Use standard dose
B. Use with caution and monitor renal function. [100% CORRECT]
C. Contraindicated
D. Double the dose
Correct Answer: B
Rationale: Correct: Metformin can be used with caution at eGFR 30-45 . Incorrect A: Dose adjustment
needed. Incorrect C: Contraindicated at eGFR <30. Incorrect D: Not appropriate.
Q7: A patient with type 2 diabetes and heart failure is started on empagliflozin. What is the cardiovascular
benefit?
A. Weight loss
B. Reduced mortality and hospitalizations. [100% CORRECT]
C. Blood pressure reduction
D. Improved lipids
Correct Answer: B
Rationale: Correct: SGLT-2 inhibitors reduce CV mortality and HF hospitalizations . Incorrect A, C, D: Also
benefits but not primary.
Q8: A patient with type 2 diabetes is started on empagliflozin. Which adverse effect is specific to this class?
